Following a continued increase of raw materials costs, Ansell Medical Solutions Europe, the regional branch of the world leader in hand protective solutions for healthcare professionals, has announced substantial price increases for its entire range of NRL medical gloves.
Increasing global market demand and adverse weather conditions in rubber-producing countries have pushed world natural rubber prices to another all-time high over the past few months.
The cost of latex in US Dollars has increased by 60 percent over the past 12 months, and 30 percent in the past three months alone. Compared with 2009, the cost of latex has more than doubled. As a result, the soaring latex price is affecting the manufacturing cost of many rubber products, including protective gloves.
In addition, the costs involved in the production of latex and synthetic gloves are also linked to the price of oil and related freight transport costs, which have also been rising steadily in past months.
"In view of our soaring costs, substantial price increases across our entire range of natural rubber latex medical gloves are essential for Ansell to be able to continue providing the high level of quality and protection our customers rightfully expect from us", says Peter Dobbelsteijn, CEO of Ansell Europe.
Ansell management is constantly monitoring trends in the cost of raw materials and is exploring all avenues aimed at offsetting future increases originating from the cost of raw materials. With a view to guaranteeing its customers the best quality products as well as the best service, Ansell maintains frequent contact with its customers and distributors regarding all major developments that impact the price of its products.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.